203 related articles for article (PubMed ID: 21760855)
21. CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.
Vallejo G; La Greca AD; Tarifa-Reischle IC; Mestre-Citrinovitz AC; Ballaré C; Beato M; Saragüeta P
PLoS One; 2014; 9(5):e97311. PubMed ID: 24859236
[TBL] [Abstract][Full Text] [Related]
22. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
Gagnon V; St-Germain ME; Parent S; Asselin E
Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
[TBL] [Abstract][Full Text] [Related]
23. Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6.
Ando H; Miyamoto T; Kashima H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
Horm Cancer; 2017 Aug; 8(4):257-267. PubMed ID: 28516379
[TBL] [Abstract][Full Text] [Related]
24. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
25. The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.
Nakamura M; Takakura M; Fujii R; Maida Y; Bono Y; Mizumoto Y; Zhang X; Kiyono T; Kyo S
Cancer Lett; 2013 Aug; 336(1):68-75. PubMed ID: 23603247
[TBL] [Abstract][Full Text] [Related]
26. SHh-Gli1 signaling pathway promotes cell survival by mediating baculoviral IAP repeat-containing 3 (BIRC3) gene in pancreatic cancer cells.
Gan H; Liu H; Zhang H; Li Y; Xu X; Xu X; Xu J
Tumour Biol; 2016 Jul; 37(7):9943-50. PubMed ID: 26815504
[TBL] [Abstract][Full Text] [Related]
27. Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.
Cao W; Gao W; Zheng P; Sun X; Wang L
BMC Med Genomics; 2019 Nov; 12(1):163. PubMed ID: 31718641
[TBL] [Abstract][Full Text] [Related]
28. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
29. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
30. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
[TBL] [Abstract][Full Text] [Related]
31. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
[TBL] [Abstract][Full Text] [Related]
33. Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer.
Liu J; Wang Z; Zhou J; Wang J; He X; Wang J
Chin Med J (Engl); 2023 Nov; 136(21):2576-2586. PubMed ID: 37144734
[TBL] [Abstract][Full Text] [Related]
34. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
Petersen SL; Peyton M; Minna JD; Wang X
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11936-41. PubMed ID: 20547836
[TBL] [Abstract][Full Text] [Related]
35. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
Diep CH; Knutson TP; Lange CA
Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor transactivation of the secretory leukocyte protease inhibitor gene in Ishikawa endometrial epithelial cells involves recruitment of Krüppel-like factor 9/basic transcription element binding protein-1.
Velarde MC; Iruthayanathan M; Eason RR; Zhang D; Simmen FA; Simmen RC
Endocrinology; 2006 Apr; 147(4):1969-78. PubMed ID: 16384861
[TBL] [Abstract][Full Text] [Related]
37. Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
Kavlashvili T; Jia Y; Dai D; Meng X; Thiel KW; Leslie KK; Yang S
PLoS One; 2016; 11(2):e0148912. PubMed ID: 26859414
[TBL] [Abstract][Full Text] [Related]
38. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
39. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
[TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]